Suzhou Highfine Biotech Co (SZSE:301393) ROCE % : 6.14% (As of Mar. 2024)

View and export this data going back to 2023. Start your Free Trial

What is Suzhou Highfine Biotech Co ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Suzhou Highfine Biotech Co's annualized ROCE % for the quarter that ended in Mar. 2024 was 6.14%.

Suzhou Highfine Biotech Co ROCE % Historical Data

The historical data trend for Suzhou Highfine Biotech Co's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Suzhou Highfine Biotech Co ROCE % Chart

Suzhou Highfine Biotech Co Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

ROCE %

Get a 7-Day Free Trial

42.87

24.50

35.26

31.22

8.30

Suzhou Highfine Biotech Co Quarterly Data
	Dec18	Dec19	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
ROCE %	Get a 7-Day Free Trial											33.08	19.20	6.42	4.07	6.14

Suzhou Highfine Biotech Co ROCE % Calculation

Suzhou Highfine Biotech Co's annualized ROCE % for the fiscal year that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	112.531	/	( ( (600.048 - 109.333)	+	(2286.942 - 65.835) )	/ 2 )
	=	112.531	/	( (490.715	+	2221.107)	/ 2 )
	=	112.531	/	1355.911
	=	8.30 %

Suzhou Highfine Biotech Co's ROCE % of for the quarter that ended in Mar. 2024 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Mar. 2024 )		(Q: Dec. 2023 )		(Q: Mar. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Mar. 2024 )		(Q: Dec. 2023 )		(Q: Mar. 2024 )
	=	136.984	/	( ( (2286.942 - 65.835)	+	(2312.149 - 70.565) )	/ 2 )
	=	136.984	/	( ( 2221.107	+	2241.584 )	/ 2 )
	=	136.984	/	2231.3455
	=	6.14 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2024) EBIT data.

Suzhou Highfine Biotech Co (SZSE:301393) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Suzhou Highfine Biotech Co ROCE % Related Terms

Thank you for viewing the detailed overview of Suzhou Highfine Biotech Co's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Suzhou Highfine Biotech Co (SZSE:301393) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Suzhou Highfine Biotech Co Ltd (SZSE:301393) » Definitions » ROCE %

Traded in Other Exchanges

N/A

Address

No. 32 Hongxi Road, F-12 Standard Factory Building, High-tech Zone, Jiangsu Province, Suzhou, CHN, 215151

Website

https://www.highfine.com

Suzhou Highfine Biotech Co Ltd is a high-tech enterprise that provides characteristic raw materials for global pharmaceutical research and development and raw material drug production companies. The products are mainly used in the fields of peptide, nucleotide and pharmaceutical synthesis. The product range covers peptide synthesis reagents for characteristic amide bond formation, molecular building blocks, protein reagents, liposome and lipid nanoparticle pharmaceutical reagents, ionic liquids , PROTAC reagents and nucleotide reagents and other types.

Suzhou Highfine Biotech Co (SZSE:301393) Headlines

No Headlines